Necrobiosis lipoidica therapy with biologicals: An ulcerated case responding to etanercept and a review of the literature

Dermatology

Volumn 221, Issue 2, 2010, Pages 117-121

  Suárez Amor, Óscar ^a   Pérez Bustillo, Alicia ^a   Ruiz González, Inmaculada ^a   Rodríguez Prieto, Manuel Ángel ^a  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

Author keywords

Biologicals; Etanercept; Infliximab; Necrobiosis lipoidica, ulcerated

Indexed keywords

ADALIMUMAB; CLOFAZIMINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; PENTOXIFYLLINE;

ADULT; ARTICLE; ATROPHY; CASE REPORT; DEBRIDEMENT; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXCISION; FATIGUE; FEMALE; HUMAN; LASER; LEG; MILIARY TUBERCULOSIS; MONOTHERAPY; NECROBIOSIS LIPOIDICA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SKIN ULCER; TELANGIECTASIA; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULIN TEST; ULCER HEALING;

ADOLESCENT; ADULT; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BIOLOGICAL PRODUCTS; CHRONIC DISEASE; COMORBIDITY; DERMATOLOGIC AGENTS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOTHYROIDISM; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LEG ULCER; MALE; MIDDLE AGED; NECROBIOSIS LIPOIDICA; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 77956326636     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314694     Document Type: Article

References (28)

1. Hammami H, Youssef S, Jaber K, Dhaoui MR, Doss N: Perforating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: a new case reported. Dermatol Online J 2008; 14: 11.
2. Pestoni C, Ferreirós MM, de la Torre C, Toribio J: Two girls with necrobiosis lipoidica and type I diabetes mellitus with transfollicular elimination in one girl. Pediatr Dermatol 2003; 20: 211-214.
3. Elmholdt TR, Sørensen HB, Fogh K: A severe case of ulcerating necrobiosis lipoidica. Acta Derm Venereol 2008; 88: 177-178.
4. Stanway A, Rademaker M, Newman P: Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol 2004; 45: 119-122.
5. Clayton TH, Harrison PV: Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 2005; 152: 581-582.
6. Darvay A, Acland KM, Russell-Jones R: Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol 1999; 141: 725-727.
7. Reinhard G, Lohmann F, Uerlich M, Bauer R, Bieber T: Successful treatment of ulcerated necrobiosis lipoidica with mycophenolate mofetil. Acta Derm Venereol 2000; 80: 312-313.
8. Noz KC, Korstanje MJ, Vermeer BJ: Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline. Clin Exp Dermatol 1993; 18: 78-79.
9. Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T: Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br J Dermatol 2005; 153: 802-807.
10. Benedix F, Geyer A, Lichte V, Metzler G, Röcken M, Strölin A: Response of ulcerated necrobiosis lipoidica to clofazimine. Acta Derm Venereol 2009; 89: 651-652.
11. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L: Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol 2008; 144: 118-119.
12. Narbutt J, Torzecka JD, Sysa-Jedrzejowska A, Zalewska A: Long-term results of topical PUVA in necrobiosis lipoidica. Clin Exp Dermatol 2006; 31: 65-67.
13. Beattie PE, Dawe RS, Ibbotson SH, Ferguson J: UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol 2006; 31: 235-238.
14. Berking C, Hegyi J, Arenberger P, Ruzicka T, Jemec GB: Photodynamic therapy of necrobiosis lipoidica: a multicenter study of 18 patients. Dermatology 2009; 218: 136-139.
15. Pasternack FR, Fox LP, Engler DE: Silicone granulomas treated with etanercept. Arch Dermatol 2005; 141: 13-15.
16. Shupack J, Siu K: Resolving granuloma annulare with etanercept. Arch Dermatol 2006; 142: 394-395.
17. Haley H, Cantrell W, Smith K: Infliximab therapy for sarcoidosis (lupus pernio). Br J Dermatol 2004; 150: 146-149.
18. España A, Sánchez-Yus E, Serna MJ, Redondo P, Robledo A, Quintanilla E: Chronic balanitis with palisading granuloma: an atypical genital localization of necrobiosis lipoidica responsive to pentoxifylline. Dermatology 1994; 188: 222-225.
19. Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA: Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003; 7: 382-386.
20. Kolde G, Muche JM, Schulze P, Fischer P, Lichey J: Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica. Dermatology 2003; 206: 180-181.
21. Cummins DL, Hiatt KM, Mimouni D, Vander Kolk CA, Cohen BA, Nousari CH: Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy. Int J Dermatol 2004; 43: 852-854.
22. Zeichner JA, Stern DW, Lebwohl M: Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006; 54:S120-S121.
23. Hu SW, Bevona C, Winterfield L, Qureshi AA, Li VW: Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case. Arch Dermatol 2009; 145: 437-439.
24. Zhang KS, Quan LT, Hsu S: Treatment of necrobiosis lipoidica with etanercept and adalimumab. Dermatol Online J 2009; 15: 12.
25. Santos-Juanes J, Galache C, Curto JR, Carrasco MP, Ribas A, Sánchez del Río J: Squamous cell carcinoma arising in longstanding necrobiosis lipoidica. J Eur Acad Dermatol Venereol 2004; 18: 199-200.
26. Smith KJ, Skelton HG: Rapid onset of cutaneous squamous cell carcinomas in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy. J Am Acad Dermatol 2001; 45: 953-956.
27. Toussirot E, Pertuiset E, Kantelip B, Wendling D: Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 2008; 26: 471-475.
28. Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA: Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis 2008; 67: 567-570.